Leon O. Moulder, Jr.

Leon O. Moulder, Jr.

Non-Executive DirectoratZenas BioPharma· In proxies 2023–2025

Pay in FY2025-77% from the year before · Zenas BioPharma stock +343.3% the same year

Leon O. Moulder, Jr. was paid $4.7M in FY2025 (Dec), down 77%. Zenas BioPharma stock rose 343.3% that year.

Pay$100 in the stock at the end of FY24 → $443
Pay is from the Summary Compensation Table of each Zenas BioPharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Zai LabPublic company · 3 yr
    • Non-Executive Director2023 – Present · 3 yrNo stock prices for these years
  2. Zenas BioPharmaPublic company · 3 yr
    • Founder, Chief Executive Officer and Chairman2023 – Present · 3 yrStock in role +59%
  3. Dianthus Therapeutics, Inc. /DE/Public company · 2 yr
    • Independent Director2024 – Present · 2 yrNo stock prices for these years
  4. Trevena, Inc.Public company · 10 yr
    • Director2013 – 2023 · 10 yrNo stock prices for these years
  5. Trevana, Inc.Public company · 12 yr
    • Director2011 – 2023 · 12 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?